Verily and Samsung are partnering to integrate data from Galaxy smartwatches into Verily’s Pre platform. The goal is to create an end-to-end system that pharma researchers can use to deploy wearable devices in studies, analyze patient data remotely and then interpret the results.
The post Verily & Samsung Team Up to Bring Smartwatch Data into Clinical Trials appeared first on MedCity News.
